Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-07 · accession 0001209191-21-055140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-08 | 2021-09-07 | PMVP | Alland Leila | Chief Medical Off | S - Sale+OE | $30.25 | -3,900 | 0 | -100% | -$118.0K |
| D | 2021-09-08 | 2021-09-07 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $3.90 | +3,900 | 3,900 | New | +$15.2K |
| D | 2021-09-08 | 2021-09-07 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $0.00 | -3,900 | 353.9K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | S | D | 3,900 | $30.25 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-07 | M | A | 3,900 | $3.90 | 3,900 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-09-07 | M | D | 3,900 | $0.00 | 353,950 | D | $3.90 · — to 2030-02-04 | 3,900 Common Stock | (F2) One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter. |